healthcare

healthcare Articles

Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in...
While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock could nearly double in the next 12 months.
GBT shares jumped on Thursday after the company announced that the FDA has accepted for filing the company’s New Drug Application for voxelotor as a treatment of sickle cell disease.
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high.
Ardelyx shares jumped on Tuesday after the firm announced positive results from its late-stage study in dialysis patients who have uncontrolled hyperphosphatemia.
Cidara Therapeutics shares saw a massive gain on Tuesday after the firm announced that it has entered into a strategic partnership with Mundipharma to develop and commercialize Cidara’s treatment...
Medicines Co. shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the treatment of low-density lipoprotein cholesterol.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
Medicines Company shares jumped early on Monday after the firm announced results from its late-stage cholesterol study of inclisiran.
Retrophin shares hit a multiyear low after the firm announced late-stage results from its study in patients with pantothenate kinase-associated neurodegeneration.